Electromed (NYSE:ELMD) Stock Rating Lowered by StockNews.com

Electromed (NYSE:ELMD) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday.

Electromed Stock Down 4.3 %

Shares of NYSE ELMD opened at $29.77 on Thursday. The stock’s 50 day moving average price is $28.56 and its two-hundred day moving average price is $21.47. Electromed has a 52-week low of $9.90 and a 52-week high of $31.88. The stock has a market capitalization of $251.85 million, a P/E ratio of 41.35 and a beta of 0.29.

Electromed (NYSE:ELMD) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.13. Electromed had a return on equity of 15.32% and a net margin of 11.34%. The business had revenue of $14.67 million for the quarter.

Insider Activity

In related news, Director Andrew Summers sold 17,463 shares of Electromed stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $30.09, for a total value of $525,461.67. Following the sale, the director now directly owns 189,838 shares in the company, valued at $5,712,225.42. This trade represents a 8.42 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 14.00% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Renaissance Technologies LLC boosted its position in Electromed by 4.8% during the 2nd quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock worth $1,548,000 after acquiring an additional 4,736 shares during the period. Pekin Hardy Strauss Inc. bought a new position in Electromed in the 2nd quarter valued at about $522,000. Gabelli Funds LLC increased its stake in Electromed by 7.8% during the 2nd quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock valued at $581,000 after buying an additional 2,808 shares during the period. Marshall Wace LLP bought a new stake in shares of Electromed during the 2nd quarter worth about $256,000. Finally, Hunter Associates Investment Management LLC lifted its stake in shares of Electromed by 12.3% in the 3rd quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock worth $2,199,000 after acquiring an additional 11,250 shares during the period. Institutional investors own 40.82% of the company’s stock.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.